Selected research
Industry Growth & Trends
Global Tumor Fluid Biopsy Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Tumor Fluid Biopsy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Tumor Fluid Biopsy is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Tumor Fluid Biopsy is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Tumor Fluid Biopsy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Tumor Fluid Biopsy market include Cellmax Life, Exact Science, Amoy Diagnostics Co, Berry Genomics Co, Genetronhealth, GenoploRare, HaploX Biotechnology Co, New Horizon Health Limited and Burning Rock Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Tumor Fluid Biopsy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Tumor Fluid Biopsy market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tumor Fluid Biopsy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tumor Fluid Biopsy.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Tumor Fluid Biopsy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Tumor Fluid Biopsy Market by Company
Cellmax Life
Exact Science
Amoy Diagnostics Co
Berry Genomics Co
Genetronhealth
GenoploRare
HaploX Biotechnology Co
New Horizon Health Limited
Burning Rock Biotech
Guangzhou Wondfo Biotech
YZY Biopharma
Tumor Fluid Biopsy Segment by Type
CTDNA Detection
CTC Detection
Other
Tumor Fluid Biopsy Segment by Application
Hospital
Third Party Organization
Other
Tumor Fluid Biopsy Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Fluid Biopsy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tumor Fluid Biopsy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Fluid Biopsy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Tumor Fluid Biopsy companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- CTDNA Detection
- CTC Detection
- Other
Applications
- Hospital
- Third Party Organization
- Other
Companies covered
- Cellmax Life
- Exact Science
- Amoy Diagnostics Co
- Berry Genomics Co
- Genetronhealth
- GenoploRare
- HaploX Biotechnology Co
- New Horizon Health Limited
- Burning Rock Biotech
- Guangzhou Wondfo Biotech
- YZY Biopharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Tumor Fluid Biopsy Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Tumor Fluid Biopsy Market Size by Region (2021-2032)
- 1.4.1 Global Tumor Fluid Biopsy Market Size by Region (2021-2026)
- 1.4.2 Global Tumor Fluid Biopsy Market Size by Region (2027-2032)
- 1.5 Key Regions Tumor Fluid Biopsy Market Size (2021-2032)
- 1.5.1 North America Tumor Fluid Biopsy Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Tumor Fluid Biopsy Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Tumor Fluid Biopsy Market Size Growth Rate (2021-2032)
- 1.5.4 South America Tumor Fluid Biopsy Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Tumor Fluid Biopsy Market Size Growth Rate (2021-2032)
2 Tumor Fluid Biopsy Market by Type
- 2.1 Type Introduction
- 2.1.1 CTDNA Detection
- 2.1.2 CTC Detection
- 2.1.3 Other
- 2.2 Global Tumor Fluid Biopsy Market Size by Type
- 2.2.1 Global Tumor Fluid Biopsy Market Size Overview by Type (2021-2032)
- 2.2.2 Global Tumor Fluid Biopsy Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Tumor Fluid Biopsy Market Size Forecasted by Type (2027-2032)
- 2.3 Global Tumor Fluid Biopsy Market Size by Regions
- 2.3.1 North America Tumor Fluid Biopsy Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Tumor Fluid Biopsy Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Tumor Fluid Biopsy Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Tumor Fluid Biopsy Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Tumor Fluid Biopsy Market Size Breakdown by Type (2021-2026)
3 Tumor Fluid Biopsy Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Third Party Organization
- 3.1.3 Other
- 3.2 Global Tumor Fluid Biopsy Market Size by Application
- 3.2.1 Global Tumor Fluid Biopsy Market Size Overview by Application (2021-2032)
- 3.2.2 Global Tumor Fluid Biopsy Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Tumor Fluid Biopsy Market Size Forecasted by Application (2027-2032)
- 3.3 Global Tumor Fluid Biopsy Market Size by Regions
- 3.3.1 North America Tumor Fluid Biopsy Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Tumor Fluid Biopsy Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Tumor Fluid Biopsy Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Tumor Fluid Biopsy Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Tumor Fluid Biopsy Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Tumor Fluid Biopsy Industry Trends
- 4.2 Tumor Fluid Biopsy Industry Drivers
- 4.3 Tumor Fluid Biopsy Industry Opportunities and Challenges
- 4.4 Tumor Fluid Biopsy Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Tumor Fluid Biopsy Revenue (2021-2026)
- 5.2 Global Tumor Fluid Biopsy Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Tumor Fluid Biopsy Key Company Headquarters & Area Served
- 5.4 Global Tumor Fluid Biopsy Company, Product Type & Application
- 5.5 Global Tumor Fluid Biopsy Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Tumor Fluid Biopsy Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Tumor Fluid Biopsy Players Market Share by Revenue in 2025
- 5.6.3 2025 Tumor Fluid Biopsy Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Cellmax Life
- 6.1.1 Cellmax Life Company Information
- 6.1.2 Cellmax Life Business Overview
- 6.1.3 Cellmax Life Tumor Fluid Biopsy Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Cellmax Life Tumor Fluid Biopsy Product Portfolio
- 6.1.5 Cellmax Life Recent Developments
- 6.2 Exact Science
- 6.2.1 Exact Science Company Information
- 6.2.2 Exact Science Business Overview
- 6.2.3 Exact Science Tumor Fluid Biopsy Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Exact Science Tumor Fluid Biopsy Product Portfolio
- 6.2.5 Exact Science Recent Developments
- 6.3 Amoy Diagnostics Co
- 6.3.1 Amoy Diagnostics Co Company Information
- 6.3.2 Amoy Diagnostics Co Business Overview
- 6.3.3 Amoy Diagnostics Co Tumor Fluid Biopsy Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Amoy Diagnostics Co Tumor Fluid Biopsy Product Portfolio
- 6.3.5 Amoy Diagnostics Co Recent Developments
- 6.4 Berry Genomics Co
- 6.4.1 Berry Genomics Co Company Information
- 6.4.2 Berry Genomics Co Business Overview
- 6.4.3 Berry Genomics Co Tumor Fluid Biopsy Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Berry Genomics Co Tumor Fluid Biopsy Product Portfolio
- 6.4.5 Berry Genomics Co Recent Developments
- 6.5 Genetronhealth
- 6.5.1 Genetronhealth Company Information
- 6.5.2 Genetronhealth Business Overview
- 6.5.3 Genetronhealth Tumor Fluid Biopsy Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Genetronhealth Tumor Fluid Biopsy Product Portfolio
- 6.5.5 Genetronhealth Recent Developments
- 6.6 GenoploRare
- 6.6.1 GenoploRare Company Information
- 6.6.2 GenoploRare Business Overview
- 6.6.3 GenoploRare Tumor Fluid Biopsy Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 GenoploRare Tumor Fluid Biopsy Product Portfolio
- 6.6.5 GenoploRare Recent Developments
- 6.7 HaploX Biotechnology Co
- 6.7.1 HaploX Biotechnology Co Company Information
- 6.7.2 HaploX Biotechnology Co Business Overview
- 6.7.3 HaploX Biotechnology Co Tumor Fluid Biopsy Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 HaploX Biotechnology Co Tumor Fluid Biopsy Product Portfolio
- 6.7.5 HaploX Biotechnology Co Recent Developments
- 6.8 New Horizon Health Limited
- 6.8.1 New Horizon Health Limited Company Information
- 6.8.2 New Horizon Health Limited Business Overview
- 6.8.3 New Horizon Health Limited Tumor Fluid Biopsy Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 New Horizon Health Limited Tumor Fluid Biopsy Product Portfolio
- 6.8.5 New Horizon Health Limited Recent Developments
- 6.9 Burning Rock Biotech
- 6.9.1 Burning Rock Biotech Company Information
- 6.9.2 Burning Rock Biotech Business Overview
- 6.9.3 Burning Rock Biotech Tumor Fluid Biopsy Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Burning Rock Biotech Tumor Fluid Biopsy Product Portfolio
- 6.9.5 Burning Rock Biotech Recent Developments
- 6.10 Guangzhou Wondfo Biotech
- 6.10.1 Guangzhou Wondfo Biotech Company Information
- 6.10.2 Guangzhou Wondfo Biotech Business Overview
- 6.10.3 Guangzhou Wondfo Biotech Tumor Fluid Biopsy Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Guangzhou Wondfo Biotech Tumor Fluid Biopsy Product Portfolio
- 6.10.5 Guangzhou Wondfo Biotech Recent Developments
- 6.11 YZY Biopharma
- 6.11.1 YZY Biopharma Company Information
- 6.11.2 YZY Biopharma Business Overview
- 6.11.3 YZY Biopharma Tumor Fluid Biopsy Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 YZY Biopharma Tumor Fluid Biopsy Product Portfolio
- 6.11.5 YZY Biopharma Recent Developments
7 North America
- 7.1 North America Tumor Fluid Biopsy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Tumor Fluid Biopsy Market Size by Country (2021-2026)
- 7.3 North America Tumor Fluid Biopsy Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Tumor Fluid Biopsy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Tumor Fluid Biopsy Market Size by Country (2021-2026)
- 8.3 Europe Tumor Fluid Biopsy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Tumor Fluid Biopsy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Tumor Fluid Biopsy Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Tumor Fluid Biopsy Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Tumor Fluid Biopsy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Tumor Fluid Biopsy Market Size by Country (2021-2026)
- 10.3 South America Tumor Fluid Biopsy Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Tumor Fluid Biopsy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Tumor Fluid Biopsy Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Tumor Fluid Biopsy Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst